Diagnostic and Interventional Cardiology DAIC

Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.

News | Artificial Intelligence

New Studies: AI Captures Electrocardiogram Patterns That Could Signal a Future Sudden Cardiac Arrest

March 1, 2024 — Two new studies by Cedars-Sinai investigators support using artificial intelligence (AI) to predict ...

March 01, 2024

New research out of VCU Massey Comprehensive Cancer Center and VCU Health Pauley Heart Center indicates that survivors of childhood cancer are at a significantly higher risk of death following a major cardiovascular event

News | Pediatric Cardiology

Long-term Survivors of Childhood Cancer at Higher Risk of Death Following Heart Issues; Threshold for Treating Risk Factors Should be Lower

February 28, 2024 — New research out of VCU Massey Comprehensive Cancer Center and VCU Health Pauley Heart Center indica ...

February 28, 2024

Health technology giant Royal Philips has announced its proposal to appoint Charlotte Hanneman as member of the Board of Management to fulfill the role of Chief Financial Officer (CFO), filling the position held by Abhijit Bhattacharya, who will be retiring at the end of September after in that role since 2015.

News | Cardiovascular Business

Philips Appoints Charlotte Hanneman to succeed Abhijit Bhattacharya as Chief Financial Officer (CFO)

February 28, 2024 — Royal Philips has announced the proposal to appoint Charlotte Hanneman as member of the Board of ...

February 28, 2024

Gen 2 System has potential to reduce cardiac workload and enhance blood flow

News | Hypertension

Aria CV Announces First Patient Successfully Implanted with Second-Generation Pulmonary Hypertension System

February 27, 2024 — Aria CV, Inc, a developer of medical devices treating pulmonary hypertension, today announced the ...

February 27, 2024

The Ohio State University Wexner Medical Center is the first in central Ohio to take part in a global clinical trial to use a novel therapy to reduce the size of the left ventricle without open-heart surgery

News | Cardiovascular Clinical Studies

Ohio State First in Central Ohio to Use Novel Heart Failure Therapy

February 26, 2024 — More than 6 million Americans live with heart failure, and about half have an enlarged left ...

February 26, 2024

The academic medical centers earned distinguished three-star ratings from The Society of Thoracic Surgeons (STS) for their patient care and outcomes in adult cardiac surgery

News | Cardiovascular Surgery

Hackensack Meridian Hackensack University and Jersey Shore University Medical Centers Again Ranked Among the Elite Hospitals in North America for Open Heart Surgery

February 26, 2024 — Hackensack Meridian Jersey Shore University Medical Center and Hackensack University Medical Center ...

February 26, 2024

The DAIC team has learned of the passing of Alain Cribier, MD, FACC, heralded as the man who pioneered the first transcatheter aortic valve replacement (TAVR) in 2002

Feature | Cardiovascular Surgery

In Memoriam: Alain Cribier, MD, FACC, TAVR Pioneer

The DAIC team has learned of the passing of Alain Cribier, MD, FACC, heralded as the man who pioneered the first transca ...

February 23, 2024

Wake Forest University School of Medicine, the academic core of Advocate Health, is expanding another research study to Advocate Christ Medical Center, in Oak Lawn, Illinois, just outside Chicago.

News | Heart Failure

Research Study on Novel Rehab Program for Heart Failure Patients, Led by Wake Forest University School of Medicine, Expands to Advocate Health Site in Chicago

February 22, 2024 — Wake Forest University School of Medicine, the academic core of Advocate Health, is expanding ...

February 22, 2024

Ismail El-Hamamsy, MD, PhD, Director of Aortic Surgery for the Mount Sinai Health System and the Mount Sinai Randall B. Griepp, MD Professor in Cardiovascular Surgery at the Icahn School of Medicine at Mount Sinai, was named as the new President of the Heart Valve Society

News | Cardiovascular Business

Ismail El-Hamamsy, MD, PhD, Named President of the Heart Valve Society

February 22, 2024 — Ismail El-Hamamsy, MD, PhD, Director of Aortic Surgery for the Mount Sinai Health System and the Mou ...

February 22, 2024

On March 25, Diagnostic and Interventional Cardiology will present a webinar on "Maximizing Structural Heart Workflows: Harnessing the Power of CVIS and AI."

News | Cardiac Imaging

Webinar on Optimizing Structural Heart Workflows to be Rescheduled

PLEASE NOTE: This webinar has been postponed to a later date.

A new date will be posted in the coming days.

...

February 29, 2024

Ochsner Children's Hospital, ranked among the top hospitals in the nation for pediatric cardiology and congenital heart surgery, is raising awareness of the need for more pediatric-specific heart devices

News | Pediatric Cardiology

Ochsner Children’s Hospital Advocates to Close the Gap in Pediatric Heart Care

February 21, 2024 — Ochsner Children's Hospital, ranked among the top hospitals in the nation for pediatric cardiology a ...

February 21, 2024

First of its kind artificial heart valve now approved by FDA for treatment of tricuspid regurgitation.

News | Cardiovascular Clinical Studies

Henry Ford Health Heart Failure Patient First in Michigan to Receive Breakthrough Device

February 21, 2024 — An 80-year-old woman from Frankenmuth, Michigan is the first Henry Ford Health structural heart ...

February 21, 2024

The Medtronic APOLLO Clinical Trial is evaluating the safety and efficacy of an investigative device called the Intrepid Transcatheter Mitral Valve Replacement System (TMVR) for moderate-to-severe or severe symptomatic mitral regurgitation (MR) in patients who may be unsuitable for approved transcatheter repair or surgery.

News | Structural Heart

Hackensack Meridian Jersey Shore University Medical Center Providing State-of-the-Art Medtronic APOLLO Clinical Trial Treating Heart Valve Disease

February 20, 2024 — As New Jersey’s leading provider of high-quality cardiac procedures and diagnostic testing and an ...

February 20, 2024

Bayer AG and Asklepios BioPharmaceutical, Inc. (AskBio), a subsidiary of Bayer AG, have announced that the first patient has been randomized in GenePHIT (Gene PHosphatase Inhibition Therapy), a Phase II trial of AB-1002, also known as NAN-101, for the treatment of congestive heart failure (CHF).

News | Cardiovascular Clinical Studies

First Patient Randomized in AskBio Phase II Gene Therapy Trial for Congestive Heart Failure Treatment

February 15, 2024 — Bayer AG and Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned and ...

February 15, 2024

Research findings in a clinical trial led by a professor at the University of Tennessee Health Science Center’s College of Nursing are likely to dramatically change care and improve outcomes for patients suffering from acute stroke.

News | Stroke

ZODIAC Clinical Trial Led by UT Health Science Center Professor Likely to Make Major Impact on Stroke Care

February 15, 2024 — Research findings in a clinical trial led by a professor at the University of Tennessee Health ...

February 15, 2024